col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Termedia Sp. z.o.o.: Archives of Medical Science
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―02 A new workflow on bone marrow aspiration and biopsy during the COVID-19 pandemic Hui Xiao, Jing He, Sanyun Wu, Hui Shen, Li Liu, Xiaoyan Liu, et al. (+4)
2 [GO] 2021―Aug―21 COVID-19: Access to Information, Health Service, Daily Life Facility and Risk Perception of Foreigners during Coronavirus pandemic in South Korea Md Nazirul Islam Sarker, Md Lamiur Raihan, Yang Peng, Tahmina Chumky, M M Kamruzzaman, Roger C Shouse, Huh Chang Deog
3 [GO] 2021―Jul―13 Continuing cancer care delivery during the peak of COVID-19 in the Bronx, New York: experience from a public teaching hospital Surabhi Pathak, Roshni Narurkar, Mohammed Hasan Khan, Bei Jiang, May Nyein Chann Soe, Caroline Hwang, et al. (+2)
4 [GO] 2021―Jul―13 Alpha-1 antitrypsin as a risk marker in SARS-CoV-2 infection José María Hernández Pérez, Juan Marco Figueira Gonçálves, Yolanda Ramallo Fariña
5 [GO] 2021―May―10 Is COVID-19 Another Case of Obesity Paradox? - Results from An International Ecological Study on behalf of the REPROGRAM Consortium Obesity Sonu Bhaskar, Sanja Jovanovic, Anubhav Katyal, Narayanan Namboodiri, Dimitrios Chatzis, Maciej Banach
6 [GO] 2021―May―10 Factors potentially influencing case fatality rate in different stages of COVID-19 outbreak in Europe Katarzyna Orlewska, Pawel Orlewski, Justyna Klusek
7 [GO] 2021―May―08 Diagnostic Accuracy of Antibody-based Rapid Diagnostic Test in Detecting Coronavirus Disease 2019: Systematic Review Yanto Tjang, Tiara Gracienta, Ryan Herardi, Frans Santosa, Taufiq Pasiak
8 [GO] 2021―May―04 Right ventricular dysfunction and pulmonary hypertension in COVID-19: a meta-analysis of prevalence and its association with clinical outcome Yudi Oktaviono, Eka Mulia, Kevin Luke, David Nugraha, Irma Maghfirah, Agus Subagjo
9 [GO] 2021―May―02 Comparative Analysis of Anxiety/Depression Scores in COVID-19 Patients with Disease Severity, Sleep Patterns, and Certain Laboratory Test Results Zi-Qiang Meng, Qi Leng, Xu Wang, Chun-Hai Xu, Jing Xu, Yan Liu
10 [GO] 2021―Apr―29 Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis Amir Vahedian-Azimi, Seyede Mohammadi, Farshad Beni, Maciej Banach, Paul Guest, Tannaz Jamialahmadi, Amirhossein Sahebkar
11 [GO] 2021―Apr―22 Bioactive lipids-based therapeutic approach to COVID-19 and other similar infections Undurti Das
12 [GO] 2021―Apr―07 Cancer screenings coverage in Poland - from bad to better and to the worst during SARS-CoV-2 pandemic Paweł Koczkodaj, Michał Kamiński, Agata Ciuba, Joanna Didkowska
13 [GO] 2021―Mar―28 Could amantadine possibly interfere with COVID-19 vaccines based on LNP-mRNA platform ? Jaroslaw Fedorowski
14 [GO] 2021―Mar―22 COVID-19 and cardiovascular complications - the preliminary results of the LATE-COVID study Joanna Lewek, Izabela Jatczak-Pawlik, Marek Maciejewski, Piotr Jankowski, Maciej Banach
15 [GO] 2021―Mar―22 Contracting COVID-19 in the First and Second trimester of pregnancy, What We Know- a Concise Qualitative Systematic Review Jasmine Abu-Amara, Dawid Szpecht, Salwan Al-Saad, Lukasz Karbowski
16 [GO] 2021―Mar―22 Clinical characteristics of COVID-19 in young patients differ from middle-aged and elderly patients Keqiang Wan, Chang Su, Lingxi Kong, Juan Liao, Wenguang Tian, Hua Luo
17 [GO] 2021―Mar―22 Big data driven COVID-19 pandemic crisis management: Potential approach for global health Yang Lv, Chenwei Ma, Xiaohan Li, Min Wu
18 [GO] 2021―Mar―22 Longitudinal investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in older patients in the province of Palermo (Southern-Italy) during the early wave of the pandemics Domenica MATRANGA, Laura Maniscalco, Marco Enea, Dario De Luca, Davide Brancato, Emanuele La Spada, et al. (+2)
19 [GO] 2021―Mar―22 Serological Testing for SARS-CoV-2 in Bosnia and Herzegovina: First report Adna Ašić, Jasminka Prguda-Mujić, Lana Salihefendić, Larisa Bešić, Daria Ler
20 [GO] 2021―Mar―22 Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease Piotr Lipiński, Jolanta Zaborniak, Piotr Garnuszek, Przemysław Szurmak
21 [GO] 2021―Mar―22 Identification of Natural Compounds (Proanthocyanidin and Rhapontin) as High-Affinity Inhibitor of SARS-CoV-2 Mpro and PLpro using Computational Strategies Mohamed AlAjmi, Asim Azhar, Sadaf Hasan, Abdullah Alshabr, Afzal Hussain, Md Tabish Rehman
22 [GO] 2021―Mar―22 Genomic Variations in SARS-CoV-2 Strains at the Target Sequences of Nucleic Acid Amplification Tests Canhui Cao, Ruidi Yu, Shaoqing Zeng, Dan Liu, Wenjian Gong, Ruyuan Li, et al. (+10)
23 [GO] 2021―Mar―03 Ethnicity and other COVID-19 death risk factors in Mexico Erwin Chiquete, Jesus Alegre-Díaz, Ana Ochoa-Guzmán, Liz Nicole Toapanta-Yanchapaxi, Carlos González-Carballo, Adrián Garcilazo-Ávila, et al. (+9)
24 [GO] 2021―Mar―03 It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window? Mostafa Ghanei
25 [GO] 2021―Mar―03 Not as black as it is painted? The impact of the first wave of COVID-19 pandemic on surgical treatment of urological cancer patients in Poland - a cross-country experience Piotr Zapała, Aleksander Ślusarczyk, Paweł Rajwa, Mikołaj Przydacz, Wojciech Krajewski, Bartosz Dybowski, et al. (+24)
26 [GO] 2021―Mar―03 Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline Elisabetta Schiaroli, Anna Gidari, Giovanni Brachelente, Sabrina Bastianelli, Alfredo Villa, Carla Ferri, Daniela Francisci
27 [GO] 2021―Mar―03 Efficacy and harms of convalescent plasma for treatment of hospitalized COVID-19 patients: a systematic review and meta-analysis Alejandro Piscoya, Luis Ng-Sueng, Angela Parra del Riego, Renato Cerna-Viacava, Vinay Pasupuleti, Priyaleela Thota, et al. (+2)
28 [GO] 2020―Sep―16 Significant COVID-19 burden in Polish children Teresa Jackowska, August Wrotek, Mateusz Jankowski, Jarosław Pinkas
29 [GO] 2020―Sep―16 COVID-19 disease: novel clinical manifestations and therapeutic exploration Chun Liu, Qiang Huang, PingXi Wang, HuaPing Wu, ShuKai Deng, Dan Liu, et al. (+4)
30 [GO] 2020―Sep―16 Changing patterns of urologic emergency visits and admissions during the COVID-19 pandemic: a retrospective, multicenter, nationwide study Pawel Rajwa, Mikolaj Przydacz, Wojciech Krajewski, Blazej Kuffel, Piotr Zapala, Aleksandra Krzywon, et al. (+32)
31 [GO] 2020―Sep―16 Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study Jun Fei, Lin Fu, Ying Li, Hui-Xian Xiang, Ying Xiang, Meng-Die Li, et al. (+3)
32 [GO] 2020―Aug―26 COVID-19 in Poland: potential associations with epidemiology, population and healthcare quality Katarzyna Orlewska, Justyna Klusek
33 [GO] 2020―Jul―26 Tocilizumab in severe COVID-19 Nicola Lucio Liberato, Andrea De Monte, Giuseppe Caravella
34 [GO] 2020―Jun―26 Game of “crowning” season 8: RAS and reproductive hormones in COVID-19 - can we end this viral series? Andrei Cosmin Cismaru, Laurentiu Gabriel Cismaru, Seyed Nabavi, Ioana Berindan-Neagoe, Emilio Clementi, Maciej Banach, Seyed Nabavi
35 [GO] 2020―Jun―15 “Celebrating old age”: an obsolete expression during the COVID-19 pandemic? Medical, social, psychological, and religious consequences of home isolation and loneliness among the elderly Alexandru Burlacu, Ionut Mavrichi, Radu Crisan-Dabija, Daniel Jugrin, Smaranda Buju, Bogdan Artene, Adrian Covic
36 [GO] 2020―May―22 Particulate matter pollution and the COVID-19 outbreak: results from Italian regions and provinces Vanessa Bianconi, Paola Bronzo, Maciej Banach, Amirhossein Sahebkar, Massimo Mannarino, Matteo Pirro
37 [GO] 2020―May―07 Statins and the COVID-19 main protease: in silico evidence on direct interaction Željko Reiner, Mahdi Hatamipour, Maciej Banach, Matteo Pirro, Khalid Al-Rasadi, Tannaz Jamialahmadi, et al. (+3)
38 [GO] 2020―May―07 Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic Niki Katsiki, Maciej Banach, Dimitri Mikhailidis
39 [GO] 2020―May―07 Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2 Seyed Nabavi, Solomon Habtemariam, Emilio Clementi, Ioana Berindan-Neagoe, Cosmin Cismaru, Mahsa Rasekhian, et al. (+5)
40 [GO] 2020―May―07 State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2 Sayed Azeez, Zahra Ghalib Alhashim, Waad Mohammed Al Otaibi, Hind Saleh Alsuwat, Abdallah M. Ibrahim, Noor B. Almandil, J. Francis Borgio
41 [GO] 2020―May―07 State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2 J. Francis Borgio, Hind Saleh Alsuwat, Waad Mohammed Al Otaibi, Abdallah M. Ibrahim, Noor Almandil, Lubna Ibrahim Al Asoom, et al. (+3)


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.008 sec